BIO International Convention 2019 - With Presentation Slides

CEO Kevin Hrusovsky took the stage in front of an enthusiastic audience this week at the BIO International Convention to share how Quanterix Simoa® ultra-sensitive biomarker technology platforms are disrupting healthcare and propelling drug discovery forward. Discover the difference Simoa Sensitivity™ makes in biomarker research and be among the first to learn about the latest Simoa innovation- the all new HD-X Analyzer!